Literature DB >> 27854516

Evasion of Neutrophil Extracellular Traps by Respiratory Pathogens.

Daniel M L Storisteanu1, Joanna M Pocock1, Andrew S Cowburn1,2, Jatinder K Juss1,3, Angalee Nadesalingam1, Victor Nizet4, Edwin R Chilvers1.   

Abstract

The release of neutrophil extracellular traps (NETs) is a major immune mechanism intended to capture pathogens. These histone- and protease-coated DNA structures are released by neutrophils in response to a variety of stimuli, including respiratory pathogens, and have been identified in the airways of patients with respiratory infection, cystic fibrosis, acute lung injury, primary graft dysfunction, and chronic obstructive pulmonary disease. NET production has been demonstrated in the lungs of mice infected with Staphylococcus aureus, Klebsiella pneumoniae, and Aspergillus fumigatus. Since the discovery of NETs over a decade ago, evidence that "NET evasion" might act as an immune protection strategy among respiratory pathogens, including group A Streptococcus, Bordetella pertussis, and Haemophilus influenzae, has been growing, with the majority of these studies being published in the past 2 years. Evasion strategies fall into three main categories: inhibition of NET release by down-regulating host inflammatory responses; degradation of NETs using pathogen-derived DNases; and resistance to the microbicidal components of NETs, which involves a variety of mechanisms, including encapsulation. Hence, the evasion of NETs appears to be a widespread strategy to allow pathogen proliferation and dissemination, and is currently a topic of intense research interest. This article outlines the evidence supporting the three main strategies of NET evasion-inhibition, degradation, and resistance-with particular reference to common respiratory pathogens.

Entities:  

Keywords:  Streptococcus; deoxyribonuclease; immune evasion; neutrophil extracellular traps

Mesh:

Year:  2017        PMID: 27854516      PMCID: PMC5449512          DOI: 10.1165/rcmb.2016-0193PS

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  50 in total

1.  Survival of bacterial biofilms within neutrophil extracellular traps promotes nontypeable Haemophilus influenzae persistence in the chinchilla model for otitis media.

Authors:  Wenzhou Hong; Richard A Juneau; Bing Pang; W Edward Swords
Journal:  J Innate Immun       Date:  2009-02-27       Impact factor: 7.349

2.  An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps.

Authors:  Katharina Beiter; Florian Wartha; Barbara Albiger; Staffan Normark; Arturo Zychlinsky; Birgitta Henriques-Normark
Journal:  Curr Biol       Date:  2006-02-21       Impact factor: 10.834

3.  Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps.

Authors:  Florian Wartha; Katharina Beiter; Barbara Albiger; Jenny Fernebro; Arturo Zychlinsky; Staffan Normark; Birgitta Henriques-Normark
Journal:  Cell Microbiol       Date:  2007-01-09       Impact factor: 3.715

4.  The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing.

Authors:  Annelies S Zinkernagel; Anjuli M Timmer; Morgan A Pence; Jeffrey B Locke; John T Buchanan; Claire E Turner; Inbal Mishalian; Shiranee Sriskandan; Emanuel Hanski; Victor Nizet
Journal:  Cell Host Microbe       Date:  2008-08-14       Impact factor: 21.023

5.  Nuclease A (Gbs0661), an extracellular nuclease of Streptococcus agalactiae, attacks the neutrophil extracellular traps and is needed for full virulence.

Authors:  Aurélie Derré-Bobillot; Naima G Cortes-Perez; Yuji Yamamoto; Pascale Kharrat; Elizabeth Couvé; Violette Da Cunha; Patrice Decker; Marie-Christophe Boissier; Frédéric Escartin; Bénédicte Cesselin; Philippe Langella; Luis G Bermúdez-Humarán; Philippe Gaudu
Journal:  Mol Microbiol       Date:  2013-07-05       Impact factor: 3.501

6.  DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection.

Authors:  Mark J Walker; Andrew Hollands; Martina L Sanderson-Smith; Jason N Cole; Joshua K Kirk; Anna Henningham; Jason D McArthur; Katrin Dinkla; Ramy K Aziz; Rita G Kansal; Amelia J Simpson; John T Buchanan; Gursharan S Chhatwal; Malak Kotb; Victor Nizet
Journal:  Nat Med       Date:  2007-07-15       Impact factor: 53.440

7.  Restoration of NET formation by gene therapy in CGD controls aspergillosis.

Authors:  Matteo Bianchi; Abdul Hakkim; Volker Brinkmann; Ulrich Siler; Reinhard A Seger; Arturo Zychlinsky; Janine Reichenbach
Journal:  Blood       Date:  2009-06-18       Impact factor: 22.113

8.  Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.

Authors:  Aaron F Carlin; Satoshi Uchiyama; Yung-Chi Chang; Amanda L Lewis; Victor Nizet; Ajit Varki
Journal:  Blood       Date:  2009-02-04       Impact factor: 22.113

9.  Lundep, a sand fly salivary endonuclease increases Leishmania parasite survival in neutrophils and inhibits XIIa contact activation in human plasma.

Authors:  Andrezza C Chagas; Fabiano Oliveira; Alain Debrabant; Jesus G Valenzuela; José M C Ribeiro; Eric Calvo
Journal:  PLoS Pathog       Date:  2014-02-06       Impact factor: 6.823

Review 10.  Neutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing?

Authors:  Bárbara Nery Porto; Renato Tetelbom Stein
Journal:  Front Immunol       Date:  2016-08-15       Impact factor: 7.561

View more
  42 in total

1.  Induction of neutrophil extracellular traps by Campylobacter jejuni.

Authors:  Sean Callahan; Ryan S Doster; Joseph W Jackson; Brittni R Kelley; Jennifer A Gaddy; Jeremiah G Johnson
Journal:  Cell Microbiol       Date:  2020-05-21       Impact factor: 3.715

Review 2.  Host-Pathogen Interactions in Gram-Positive Bacterial Pneumonia.

Authors:  Jennifer A Grousd; Helen E Rich; John F Alcorn
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

3.  Dysregulation of the glutaredoxin/S-glutathionylation redox axis in lung diseases.

Authors:  Shi B Chia; Evan A Elko; Reem Aboushousha; Allison M Manuel; Cheryl van de Wetering; Joseph E Druso; Jos van der Velden; David J Seward; Vikas Anathy; Charles G Irvin; Ying-Wai Lam; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-06       Impact factor: 4.249

Review 4.  Neutrophils and Bacterial Immune Evasion.

Authors:  Scott D Kobayashi; Natalia Malachowa; Frank R DeLeo
Journal:  J Innate Immun       Date:  2018-04-11       Impact factor: 7.349

5.  Z-form extracellular DNA is a structural component of the bacterial biofilm matrix.

Authors:  John R Buzzo; Aishwarya Devaraj; Erin S Gloag; Joseph A Jurcisek; Frank Robledo-Avila; Theresa Kesler; Kathryn Wilbanks; Lauren Mashburn-Warren; Sabarathnam Balu; Joseph Wickham; Laura A Novotny; Paul Stoodley; Lauren O Bakaletz; Steven D Goodman
Journal:  Cell       Date:  2021-11-03       Impact factor: 41.582

6.  Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury.

Authors:  Emma Lefrançais; Beñat Mallavia; Hanjing Zhuo; Carolyn S Calfee; Mark R Looney
Journal:  JCI Insight       Date:  2018-02-08

7.  Heterogeneity of human serum antibody responses to P. gingivalis in periodontitis: Effects of age, race/ethnicity, and sex.

Authors:  J L Ebersole; M Al-Sabbagh; D R Dawson
Journal:  Immunol Lett       Date:  2019-12-18       Impact factor: 3.685

Review 8.  Neutrophil Extracellular Traps in Host Defense.

Authors:  Sabrina Sofia Burgener; Kate Schroder
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-07-01       Impact factor: 9.708

Review 9.  Cell death as part of innate immunity: Cause or consequence?

Authors:  Mario Riera Romo
Journal:  Immunology       Date:  2021-04-13       Impact factor: 7.215

Review 10.  The Role of Neutrophil Extracellular Traps in Central Nervous System Diseases and Prospects for Clinical Application.

Authors:  Yinghan Guo; Hanhai Zeng; Chen Gao
Journal:  Oxid Med Cell Longev       Date:  2021-07-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.